CN Stock MarketDetailed Quotes

600750 Jiangzhong Pharmaceutical

Watchlist
  • 21.02
  • -0.36-1.68%
Market Closed Dec 13 15:00 CST
13.22BMarket Cap17.62P/E (TTM)

Jiangzhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-64.66%907.98M
-56.42%1.15B
-36.24%1.34B
-2.80%1.33B
113.25%2.57B
116.87%2.63B
81.15%2.1B
31.09%1.37B
24.67%1.2B
46.89%1.21B
Transactional financial assets
----
----
-84.92%100.64M
-96.36%50.02M
-83.49%232M
-88.14%178.53M
-56.60%667.13M
-20.54%1.37B
34.12%1.41B
17.97%1.51B
Notes receivable and accounts receivable
53.65%403.53M
53.66%494.21M
45.39%557.28M
31.56%410.31M
-18.46%262.63M
5.64%321.63M
-58.91%383.3M
1.19%311.88M
-60.76%322.09M
-67.00%304.46M
-Notes receivable
--107.77M
--216.02M
--308.95M
--158.54M
----
----
----
----
----
----
-Accounts receivable
12.62%295.76M
-13.50%278.2M
-35.21%248.33M
-19.27%251.77M
-18.46%262.63M
5.64%321.63M
17.12%383.3M
1.19%311.88M
94.05%322.09M
76.30%304.46M
Other receivables (including interest and dividends)
82.71%42.72M
26.45%35.3M
-49.29%22.62M
-63.21%15.91M
-55.58%23.38M
-49.77%27.91M
-20.06%44.61M
-9.98%43.26M
0.90%52.65M
141.96%55.58M
-Other receivable
----
26.45%35.3M
----
----
----
-49.77%27.91M
----
-9.98%43.26M
----
288.21%55.58M
Advance payment
-20.50%48.15M
4.17%53.82M
-52.87%44.38M
-47.19%43M
-28.73%60.56M
-28.46%51.66M
28.21%94.16M
58.18%81.42M
-68.75%84.98M
-44.40%72.21M
Inventories
6.79%442.4M
10.20%406.71M
0.62%357.55M
4.98%406.17M
17.54%414.28M
5.87%369.07M
4.87%355.36M
2.36%386.9M
27.50%352.47M
33.16%348.61M
Receivable financing
-54.64%176.13M
-69.94%80.59M
-14.78%362.25M
-70.96%134.6M
-38.06%388.28M
-38.37%268.09M
924.70%425.07M
-4.48%463.57M
1,530.19%626.89M
1,251.93%434.99M
Other current assets
-15.65%7.49M
54.15%13.58M
-35.75%6.58M
-81.93%4.2M
-62.92%8.87M
-55.11%8.81M
-40.18%10.24M
18.21%23.22M
151.37%23.93M
162.07%19.62M
Total current assets
-48.77%2.03B
-42.14%2.23B
-31.60%2.79B
-40.88%2.4B
-2.79%3.96B
-2.51%3.85B
-1.87%4.08B
-0.25%4.05B
16.71%4.07B
13.43%3.95B
Non Current assets
Other non-current financial assets
-34.82%81.57M
-41.10%81.57M
-41.10%81.57M
-41.10%81.57M
4.94%125.15M
16.13%138.5M
16.13%138.5M
16.13%138.5M
7.19%119.26M
7.19%119.26M
Long-term equity investment
-17.27%30.94M
-15.05%30.82M
-13.85%31.09M
-14.12%31.3M
-1.11%37.39M
-3.80%36.28M
-11.34%36.09M
-7.75%36.44M
-15.69%37.81M
-15.04%37.72M
Fixed assets
----
43.31%1.52B
----
----
----
-0.24%1.06B
----
4.54%1.07B
----
7.81%1.06B
Constru in process
----
-90.52%50.11M
----
----
----
131.95%528.51M
----
133.62%445.67M
----
1,349.33%227.86M
Intangible assets
-3.50%391.03M
-3.86%393.43M
5.94%397.02M
5.81%401.1M
5.75%405.2M
5.66%409.21M
-4.27%374.74M
-4.17%379.07M
3.00%383.17M
3.19%387.29M
Development expenditure
----
----
----
----
--2.55M
--2.55M
--2.55M
----
----
----
Goodwill
0.00%41.74M
0.00%41.74M
0.00%41.74M
0.00%41.74M
0.00%41.74M
0.00%41.74M
0.00%41.74M
0.00%41.74M
182.50%41.74M
182.50%41.74M
Long deferred expense
168.06%4.37M
147.66%4.22M
89.35%4.44M
100.85%4.66M
-32.50%1.63M
-32.28%1.7M
-12.36%2.34M
-16.33%2.32M
383.30%2.42M
390.67%2.52M
Deferred tax assets
54.20%63.82M
38.22%57.83M
43.71%58.69M
35.99%60.45M
11.86%41.38M
10.42%41.84M
5.57%40.84M
-1.00%44.45M
22.46%37M
-6.06%37.89M
Usufruct assets
-50.55%1.76M
-48.36%2.12M
-14.93%1.91M
-14.34%2.34M
10.74%3.56M
10.69%4.1M
-44.55%2.24M
-37.46%2.73M
943.16%3.22M
943.88%3.71M
Other non current assets
4,083.37%1.92B
3,109.24%1.74B
2,106.73%1.53B
2,463.81%1.51B
-53.92%45.85M
-37.39%54.12M
-4.47%69.15M
-14.43%59.02M
40.15%99.51M
45.12%86.43M
Total non current assets
79.74%4.1B
68.99%3.91B
66.87%3.74B
67.94%3.73B
9.61%2.28B
15.54%2.32B
15.55%2.24B
14.93%2.22B
25.51%2.08B
21.81%2.01B
Total assets
-1.81%6.13B
-0.41%6.14B
3.33%6.53B
-2.35%6.13B
1.40%6.24B
3.57%6.17B
3.67%6.32B
4.65%6.28B
19.54%6.15B
16.12%5.96B
Liabilities
Current liabilities
Notes payable and accounts payable
-37.42%113.56M
-24.15%119.67M
-22.69%168.03M
-34.02%156.25M
-25.59%181.46M
-30.12%157.78M
-20.40%217.34M
15.11%236.81M
267.21%243.86M
253.53%225.8M
-Notes payable
----
----
137.89%27.33M
-30.41%37.9M
-84.83%10.57M
----
-20.49%11.49M
27.77%54.46M
--69.65M
--14.63M
-Accounts payable
-33.55%113.56M
-24.15%119.67M
-31.65%140.69M
-35.09%118.35M
-1.90%170.89M
-25.28%157.78M
-20.40%205.85M
11.80%182.34M
162.32%174.21M
230.62%211.17M
Contract liabilities
35.96%193.72M
18.70%237.15M
62.69%276.84M
-18.54%292.16M
18.36%142.49M
29.42%199.78M
-20.86%170.16M
19.57%358.66M
35.52%120.38M
-20.05%154.37M
Salaries payable
-31.45%82.68M
-7.24%102.27M
-4.41%93.11M
7.95%177.12M
29.90%120.61M
48.40%110.25M
50.50%97.41M
21.79%164.07M
28.42%92.84M
15.92%74.29M
Taxs payable
-9.56%67.51M
18.53%99.79M
47.82%124.38M
17.36%88.38M
-20.61%74.65M
-29.76%84.19M
-10.58%84.14M
53.98%75.31M
80.89%94.03M
97.94%119.85M
Other payable (including interest and dividends)
44.03%1.31B
-0.26%931.7M
5.53%930.64M
-1.40%786.21M
14.37%911.81M
35.16%934.16M
54.09%881.9M
27.47%797.42M
149.06%797.24M
146.19%691.15M
-Dividend payable
--315.48M
--67.97M
----
--13.34M
----
----
----
----
----
----
-Other payable
----
-7.54%863.73M
----
----
----
35.16%934.16M
----
27.73%797.42M
----
146.19%691.15M
Non current liabilities due within one year
-64.98%665.25K
-62.30%1.02M
-52.73%975.99K
-37.01%1.25M
0.55%1.9M
30.11%2.7M
104.41%2.06M
16.85%1.99M
--1.89M
--2.08M
Other current liabilities
30.16%24.1M
183.82%73.74M
202.54%62.36M
94.67%84.57M
24.77%18.51M
--25.98M
--20.61M
--43.44M
--14.84M
----
Total current liabilities
23.71%1.8B
3.33%1.57B
12.40%1.66B
-5.47%1.59B
6.33%1.45B
19.51%1.51B
20.77%1.47B
27.43%1.68B
127.66%1.37B
91.38%1.27B
Current liabilities
Deferred tax liabilities
-6.86%16.67M
-19.02%16.54M
-18.98%17.02M
-18.95%17.5M
-12.26%17.9M
-3.60%20.43M
-4.30%21.01M
-4.95%21.59M
12.98%20.4M
12.89%21.19M
Long term deferred income
50.78%81.47M
33.62%84.75M
40.20%91.95M
-27.87%48.94M
-22.75%54.04M
-10.76%63.43M
-8.24%65.59M
-7.12%67.85M
14.49%69.95M
24.30%71.07M
Lease liabilities
-46.66%1.09M
-51.56%1.07M
0.64%897.18K
-10.90%1.05M
35.77%2.05M
0.33%2.21M
-74.00%891.48K
-57.86%1.18M
383.42%1.51M
516.33%2.2M
Total non current liabilities
34.14%99.23M
18.94%102.36M
25.58%109.87M
-25.52%67.48M
-19.46%73.98M
-8.90%86.06M
-9.67%87.49M
-8.06%90.61M
15.59%91.85M
23.79%94.46M
Total liabilities
24.21%1.89B
4.17%1.67B
13.14%1.77B
-6.50%1.65B
4.70%1.53B
17.54%1.6B
18.53%1.56B
24.96%1.77B
114.55%1.46B
84.40%1.36B
Shareholders equity
Paid-in capital
-0.05%629.13M
-0.05%629.13M
-0.03%629.33M
-0.04%629.36M
-0.02%629.44M
-0.07%629.44M
-0.07%629.55M
-0.07%629.58M
-0.07%629.58M
-0.01%629.91M
Capital reserve funds
2.19%427.94M
2.46%426.68M
2.75%426.05M
-0.57%424.9M
2.77%418.76M
1.45%416.45M
1.68%414.66M
4.79%427.35M
-6.41%407.47M
-5.71%410.48M
Surplus reserve funds
0.00%356.39M
0.00%356.39M
0.00%356.39M
0.00%356.39M
0.00%356.39M
0.00%356.39M
0.00%356.39M
0.00%356.39M
15.85%356.39M
15.85%356.39M
Retained profit
-14.34%2.32B
-2.98%2.49B
-2.20%2.7B
-3.35%2.44B
-1.58%2.7B
-2.78%2.56B
-2.50%2.76B
-4.92%2.52B
-1.36%2.75B
-0.20%2.64B
Less:Treasury stock
-54.62%12.27M
-54.62%12.27M
-47.98%16.3M
-47.87%16.42M
-21.47%27.05M
-26.60%27.05M
-27.61%31.33M
-27.21%31.5M
-52.99%34.44M
--36.85M
Shareholders equity without minority interests
-8.92%3.72B
-1.31%3.89B
-0.84%4.1B
-1.84%3.83B
-0.61%4.08B
-1.45%3.94B
-1.25%4.13B
-2.49%3.9B
0.53%4.11B
-0.45%4B
Minority interests
-18.70%514.13M
-6.44%590.89M
6.40%661.35M
6.48%643.59M
7.23%632.35M
5.25%631.55M
5.47%621.6M
4.31%604.41M
53.93%589.7M
58.67%600.02M
Total shareholder equity
-10.23%4.23B
-2.02%4.48B
0.11%4.76B
-0.73%4.48B
0.38%4.71B
-0.57%4.57B
-0.42%4.76B
-1.63%4.51B
5.10%4.7B
4.64%4.6B
Total liabilityies and equity
-1.81%6.13B
-0.41%6.14B
3.33%6.53B
-2.35%6.13B
1.40%6.24B
3.57%6.17B
3.67%6.32B
4.65%6.28B
19.54%6.15B
16.12%5.96B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -64.66%907.98M-56.42%1.15B-36.24%1.34B-2.80%1.33B113.25%2.57B116.87%2.63B81.15%2.1B31.09%1.37B24.67%1.2B46.89%1.21B
Transactional financial assets ---------84.92%100.64M-96.36%50.02M-83.49%232M-88.14%178.53M-56.60%667.13M-20.54%1.37B34.12%1.41B17.97%1.51B
Notes receivable and accounts receivable 53.65%403.53M53.66%494.21M45.39%557.28M31.56%410.31M-18.46%262.63M5.64%321.63M-58.91%383.3M1.19%311.88M-60.76%322.09M-67.00%304.46M
-Notes receivable --107.77M--216.02M--308.95M--158.54M------------------------
-Accounts receivable 12.62%295.76M-13.50%278.2M-35.21%248.33M-19.27%251.77M-18.46%262.63M5.64%321.63M17.12%383.3M1.19%311.88M94.05%322.09M76.30%304.46M
Other receivables (including interest and dividends) 82.71%42.72M26.45%35.3M-49.29%22.62M-63.21%15.91M-55.58%23.38M-49.77%27.91M-20.06%44.61M-9.98%43.26M0.90%52.65M141.96%55.58M
-Other receivable ----26.45%35.3M-------------49.77%27.91M-----9.98%43.26M----288.21%55.58M
Advance payment -20.50%48.15M4.17%53.82M-52.87%44.38M-47.19%43M-28.73%60.56M-28.46%51.66M28.21%94.16M58.18%81.42M-68.75%84.98M-44.40%72.21M
Inventories 6.79%442.4M10.20%406.71M0.62%357.55M4.98%406.17M17.54%414.28M5.87%369.07M4.87%355.36M2.36%386.9M27.50%352.47M33.16%348.61M
Receivable financing -54.64%176.13M-69.94%80.59M-14.78%362.25M-70.96%134.6M-38.06%388.28M-38.37%268.09M924.70%425.07M-4.48%463.57M1,530.19%626.89M1,251.93%434.99M
Other current assets -15.65%7.49M54.15%13.58M-35.75%6.58M-81.93%4.2M-62.92%8.87M-55.11%8.81M-40.18%10.24M18.21%23.22M151.37%23.93M162.07%19.62M
Total current assets -48.77%2.03B-42.14%2.23B-31.60%2.79B-40.88%2.4B-2.79%3.96B-2.51%3.85B-1.87%4.08B-0.25%4.05B16.71%4.07B13.43%3.95B
Non Current assets
Other non-current financial assets -34.82%81.57M-41.10%81.57M-41.10%81.57M-41.10%81.57M4.94%125.15M16.13%138.5M16.13%138.5M16.13%138.5M7.19%119.26M7.19%119.26M
Long-term equity investment -17.27%30.94M-15.05%30.82M-13.85%31.09M-14.12%31.3M-1.11%37.39M-3.80%36.28M-11.34%36.09M-7.75%36.44M-15.69%37.81M-15.04%37.72M
Fixed assets ----43.31%1.52B-------------0.24%1.06B----4.54%1.07B----7.81%1.06B
Constru in process -----90.52%50.11M------------131.95%528.51M----133.62%445.67M----1,349.33%227.86M
Intangible assets -3.50%391.03M-3.86%393.43M5.94%397.02M5.81%401.1M5.75%405.2M5.66%409.21M-4.27%374.74M-4.17%379.07M3.00%383.17M3.19%387.29M
Development expenditure ------------------2.55M--2.55M--2.55M------------
Goodwill 0.00%41.74M0.00%41.74M0.00%41.74M0.00%41.74M0.00%41.74M0.00%41.74M0.00%41.74M0.00%41.74M182.50%41.74M182.50%41.74M
Long deferred expense 168.06%4.37M147.66%4.22M89.35%4.44M100.85%4.66M-32.50%1.63M-32.28%1.7M-12.36%2.34M-16.33%2.32M383.30%2.42M390.67%2.52M
Deferred tax assets 54.20%63.82M38.22%57.83M43.71%58.69M35.99%60.45M11.86%41.38M10.42%41.84M5.57%40.84M-1.00%44.45M22.46%37M-6.06%37.89M
Usufruct assets -50.55%1.76M-48.36%2.12M-14.93%1.91M-14.34%2.34M10.74%3.56M10.69%4.1M-44.55%2.24M-37.46%2.73M943.16%3.22M943.88%3.71M
Other non current assets 4,083.37%1.92B3,109.24%1.74B2,106.73%1.53B2,463.81%1.51B-53.92%45.85M-37.39%54.12M-4.47%69.15M-14.43%59.02M40.15%99.51M45.12%86.43M
Total non current assets 79.74%4.1B68.99%3.91B66.87%3.74B67.94%3.73B9.61%2.28B15.54%2.32B15.55%2.24B14.93%2.22B25.51%2.08B21.81%2.01B
Total assets -1.81%6.13B-0.41%6.14B3.33%6.53B-2.35%6.13B1.40%6.24B3.57%6.17B3.67%6.32B4.65%6.28B19.54%6.15B16.12%5.96B
Liabilities
Current liabilities
Notes payable and accounts payable -37.42%113.56M-24.15%119.67M-22.69%168.03M-34.02%156.25M-25.59%181.46M-30.12%157.78M-20.40%217.34M15.11%236.81M267.21%243.86M253.53%225.8M
-Notes payable --------137.89%27.33M-30.41%37.9M-84.83%10.57M-----20.49%11.49M27.77%54.46M--69.65M--14.63M
-Accounts payable -33.55%113.56M-24.15%119.67M-31.65%140.69M-35.09%118.35M-1.90%170.89M-25.28%157.78M-20.40%205.85M11.80%182.34M162.32%174.21M230.62%211.17M
Contract liabilities 35.96%193.72M18.70%237.15M62.69%276.84M-18.54%292.16M18.36%142.49M29.42%199.78M-20.86%170.16M19.57%358.66M35.52%120.38M-20.05%154.37M
Salaries payable -31.45%82.68M-7.24%102.27M-4.41%93.11M7.95%177.12M29.90%120.61M48.40%110.25M50.50%97.41M21.79%164.07M28.42%92.84M15.92%74.29M
Taxs payable -9.56%67.51M18.53%99.79M47.82%124.38M17.36%88.38M-20.61%74.65M-29.76%84.19M-10.58%84.14M53.98%75.31M80.89%94.03M97.94%119.85M
Other payable (including interest and dividends) 44.03%1.31B-0.26%931.7M5.53%930.64M-1.40%786.21M14.37%911.81M35.16%934.16M54.09%881.9M27.47%797.42M149.06%797.24M146.19%691.15M
-Dividend payable --315.48M--67.97M------13.34M------------------------
-Other payable -----7.54%863.73M------------35.16%934.16M----27.73%797.42M----146.19%691.15M
Non current liabilities due within one year -64.98%665.25K-62.30%1.02M-52.73%975.99K-37.01%1.25M0.55%1.9M30.11%2.7M104.41%2.06M16.85%1.99M--1.89M--2.08M
Other current liabilities 30.16%24.1M183.82%73.74M202.54%62.36M94.67%84.57M24.77%18.51M--25.98M--20.61M--43.44M--14.84M----
Total current liabilities 23.71%1.8B3.33%1.57B12.40%1.66B-5.47%1.59B6.33%1.45B19.51%1.51B20.77%1.47B27.43%1.68B127.66%1.37B91.38%1.27B
Current liabilities
Deferred tax liabilities -6.86%16.67M-19.02%16.54M-18.98%17.02M-18.95%17.5M-12.26%17.9M-3.60%20.43M-4.30%21.01M-4.95%21.59M12.98%20.4M12.89%21.19M
Long term deferred income 50.78%81.47M33.62%84.75M40.20%91.95M-27.87%48.94M-22.75%54.04M-10.76%63.43M-8.24%65.59M-7.12%67.85M14.49%69.95M24.30%71.07M
Lease liabilities -46.66%1.09M-51.56%1.07M0.64%897.18K-10.90%1.05M35.77%2.05M0.33%2.21M-74.00%891.48K-57.86%1.18M383.42%1.51M516.33%2.2M
Total non current liabilities 34.14%99.23M18.94%102.36M25.58%109.87M-25.52%67.48M-19.46%73.98M-8.90%86.06M-9.67%87.49M-8.06%90.61M15.59%91.85M23.79%94.46M
Total liabilities 24.21%1.89B4.17%1.67B13.14%1.77B-6.50%1.65B4.70%1.53B17.54%1.6B18.53%1.56B24.96%1.77B114.55%1.46B84.40%1.36B
Shareholders equity
Paid-in capital -0.05%629.13M-0.05%629.13M-0.03%629.33M-0.04%629.36M-0.02%629.44M-0.07%629.44M-0.07%629.55M-0.07%629.58M-0.07%629.58M-0.01%629.91M
Capital reserve funds 2.19%427.94M2.46%426.68M2.75%426.05M-0.57%424.9M2.77%418.76M1.45%416.45M1.68%414.66M4.79%427.35M-6.41%407.47M-5.71%410.48M
Surplus reserve funds 0.00%356.39M0.00%356.39M0.00%356.39M0.00%356.39M0.00%356.39M0.00%356.39M0.00%356.39M0.00%356.39M15.85%356.39M15.85%356.39M
Retained profit -14.34%2.32B-2.98%2.49B-2.20%2.7B-3.35%2.44B-1.58%2.7B-2.78%2.56B-2.50%2.76B-4.92%2.52B-1.36%2.75B-0.20%2.64B
Less:Treasury stock -54.62%12.27M-54.62%12.27M-47.98%16.3M-47.87%16.42M-21.47%27.05M-26.60%27.05M-27.61%31.33M-27.21%31.5M-52.99%34.44M--36.85M
Shareholders equity without minority interests -8.92%3.72B-1.31%3.89B-0.84%4.1B-1.84%3.83B-0.61%4.08B-1.45%3.94B-1.25%4.13B-2.49%3.9B0.53%4.11B-0.45%4B
Minority interests -18.70%514.13M-6.44%590.89M6.40%661.35M6.48%643.59M7.23%632.35M5.25%631.55M5.47%621.6M4.31%604.41M53.93%589.7M58.67%600.02M
Total shareholder equity -10.23%4.23B-2.02%4.48B0.11%4.76B-0.73%4.48B0.38%4.71B-0.57%4.57B-0.42%4.76B-1.63%4.51B5.10%4.7B4.64%4.6B
Total liabilityies and equity -1.81%6.13B-0.41%6.14B3.33%6.53B-2.35%6.13B1.40%6.24B3.57%6.17B3.67%6.32B4.65%6.28B19.54%6.15B16.12%5.96B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%
ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.84%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%